Folinext Gold Tablet by Aristo — wholesale price and bulk supply

About Folinext Gold Tablet

Folinext Gold Tablet is a tablet pharmaceutical product marketed by Aristo containing Folic Acid 5mg + Cyanocobalamin 1500mcg + Pyridoxine 3mg, available for wholesale and bulk purchase on PharmaBag.

Folinext Gold Tablet specifications

Product specifications
Product NameFolinext Gold Tablet
Salt CompositionFolic Acid 5mg + Cyanocobalamin 1500mcg + Pyridoxine 3mg
Manufacturer / MarketerAristo
Dosage FormTablet
Product CategoryEthical

Prices are wholesale rates offered by verified suppliers and exclude GST unless stated. Product information is provided for trade reference only and is not medical advice. Always verify the pack, batch and prescribing information before dispensing.

Frequently asked questions about Folinext Gold Tablet

What is the salt composition of Folinext Gold Tablet?

Folinext Gold Tablet contains Folic Acid 5mg + Cyanocobalamin 1500mcg + Pyridoxine 3mg. Always confirm the composition and strength against the product pack and the prescribing information before dispensing.

Who manufactures Folinext Gold Tablet?

Folinext Gold Tablet is marketed by Aristo. PharmaBag sources it through verified wholesale suppliers who hold valid drug licences.

Can I buy Folinext Gold Tablet in bulk for my pharmacy or hospital?

Yes. PharmaBag is a B2B wholesale platform serving retail pharmacies, hospitals, clinics and distributors across India. Buyers complete a one-time verification with a drug licence and GST or PAN details, after which Folinext Gold Tablet can be ordered in bulk with a GST invoice and pan-India delivery.

Is a GST invoice provided for Folinext Gold Tablet?

Yes. Every order placed on PharmaBag, including Folinext Gold Tablet, is billed with a GST invoice from the supplying wholesaler at the applicable GST rate.

Alternatives to Folinext Gold Tablet

Other wholesale medicines with a comparable salt composition (Folic Acid 5mg).

More from Aristo

View all Aristo products →

Browse by generic molecule